主动脉瓣狭窄的全生命周期管理
Life-time Management of Aortic Stenosis
09/12 09:30-10:30
TAVI培训·AI双语字幕（5楼 水晶厅 - Ⅲ） (TAVI Track - AI Subtitles (5F Crystal Hall - III))
-
09:30-10:30
-
09:30-10:30
-
09:30-10:30学习目标 • 为更年轻、低危主动脉瓣狭窄患者规划最优的终身瓣膜策略 • 运用现有证据在 TAVI 与 SAVR 间决策 • 面向未来可能的再次干预优化首次 TAVI 瓣膜选择及技术策略Session Objectives • Plan the optimal lifelong strategy for younger, lower-risk patients with aortic stenosis • Understand how to decide between TAVI and SAVR using current evidence • Optimise the first TAVI valve choice and implant techniques for the future
-
09:30-09:40年轻及低危患者中 TAVI 与 SAVR 长期效果的比较：里程碑临床试验的启示Durability of TAVI versus SAVR in younger and lower-risk patients: implications of landmark clinical trials
-
09:40-09:45讨论与观众互动Discussion and audience interaction
-
09:45-09:55年轻主动脉瓣狭窄患者的 TAVI：如何优化首次瓣膜选择TAVI in younger patients with aortic stenosis: how to optimize the first TAVI valve selection
-
09:55-10:00讨论与观众互动Discussion and audience interaction
-
10:00-10:10年轻主动脉瓣狭窄患者的 TAVI：如何为未来优化手术技术TAVI in younger patients with aortic stenosis: how to optimize procedural techniques for the future
-
10:10-10:15讨论与观众互动Discussion and audience interaction
-
10:15-10:25TAVR全生命周期策略优化：介入外科医生视角Optimizing the lifetime management strategy for TAVR: perspectives of an interventional surgeon
-
10:25-10:30讨论与观众互动Discussion and audience interaction